Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP815407.RAkFVBfKhFPRdSTh5FXdTNqFcBC0saCc-k0RbxmhRV38k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP815407.RAkFVBfKhFPRdSTh5FXdTNqFcBC0saCc-k0RbxmhRV38k130_assertion type Assertion NP815407.RAkFVBfKhFPRdSTh5FXdTNqFcBC0saCc-k0RbxmhRV38k130_head.
- NP815407.RAkFVBfKhFPRdSTh5FXdTNqFcBC0saCc-k0RbxmhRV38k130_assertion description "[Recurrent somatic ASXL1 mutations occur in patients with myelodysplastic syndrome, myeloproliferative neoplasms, and acute myeloid leukemia, and are associated with adverse outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815407.RAkFVBfKhFPRdSTh5FXdTNqFcBC0saCc-k0RbxmhRV38k130_provenance.
- NP815407.RAkFVBfKhFPRdSTh5FXdTNqFcBC0saCc-k0RbxmhRV38k130_assertion evidence source_evidence_literature NP815407.RAkFVBfKhFPRdSTh5FXdTNqFcBC0saCc-k0RbxmhRV38k130_provenance.
- NP815407.RAkFVBfKhFPRdSTh5FXdTNqFcBC0saCc-k0RbxmhRV38k130_assertion SIO_000772 22897849 NP815407.RAkFVBfKhFPRdSTh5FXdTNqFcBC0saCc-k0RbxmhRV38k130_provenance.
- NP815407.RAkFVBfKhFPRdSTh5FXdTNqFcBC0saCc-k0RbxmhRV38k130_assertion wasDerivedFrom befree-20140225 NP815407.RAkFVBfKhFPRdSTh5FXdTNqFcBC0saCc-k0RbxmhRV38k130_provenance.
- NP815407.RAkFVBfKhFPRdSTh5FXdTNqFcBC0saCc-k0RbxmhRV38k130_assertion wasGeneratedBy ECO_0000203 NP815407.RAkFVBfKhFPRdSTh5FXdTNqFcBC0saCc-k0RbxmhRV38k130_provenance.